On Tuesday 2 June 2020, Q-linea announced the successful completion of a directed issue of 4 million shares at a price of SEK 67.50 per share, raising proceeds of SEK 270m. The directed share issue attracted very strong interest from Swedish and international high quality institutional investors and was heavily oversubscribed. The price was determined in an accelerated book building process and corresponded to a discount of 2.5 percent in relation to the closing price on Nasdaq Stockholm on 2 June 2020. Q-linea intends to use the net proceeds from the directed share issue for funding the commercial launch of ASTar, including production ramp-up in order to meet estimated sales volumes; acceleration of development of ASTar additional assays and new products; and general corporate purposes, such as strengthening the working capital position in order to handle potential long term effects on operations due to COVID-19.

Contact

Conny Granelli

Investment Banking

Conny.Granelli@abgsc.se +46 8 566 286 79
Benjamin Nordin

Benjamin Nordin

Investment Banking

Benjamin.Nordin@abgsc.se +46 8 566 286 98